Genetic Technologies Limited (GTG) is diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women’s health. The Company’s lead product is BREVAGenplus. In May 2019, the Company announced that it had developed two new cancer risk assessment tests branded as ‘GeneType for Colorectal Cancer’ and ‘GeneType for Breast Cancer’
Genetic Technologies Limited operators in Health Care sector and under industry of Life Sciences Tools & Services. The company website is: http://www.gtglabs.com.
You can also check out dividend history for similar stocks in the same sector as follows:
GTG Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found